- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06792305
The Sequence of Fixation in Tile C1.2 and C1.3 Vertical Shear Pelvic Ring Injuries.
January 23, 2025 updated by: Karim Atef Salem, Ain Shams University
SEQUENCE of FIXATION in VERTICALLY UNSTABLE TILE C1.2 and C1.3 PELVIC RING INJURIES: a PROSPECTIVE COMPARATIVE STUDY
The goal of this study is to compare the sequence of fixation in Vertically Unstable Tile C1.2 and C1.3 pelvic ring injuries, as regards clinical, radiological outcomes and implant failure rates.
Our hypothesis is that starting with anterior ring fixation will achieve superior results as regards easier reduction, less operation time, and finally better radiological and functional outcomes when compared with starting with posterior ring fixation.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Karim Salem, Masters of Orthopedic surgery
- Phone Number: +20 1000017388
- Email: karimatefsalem@gmail.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Ainshams university hospitals
-
Contact:
- Karim Salem, Master of Orthopedic surgery
- Phone Number: +20 1000017388
- Email: karimatefsalem@gmail.com
-
Contact:
- Karim Salem, Masters of Orthopedic surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age: 18 years - 60 years.
- Tile C1.2 and C1.3 pelvic ring injuries.
- Pure anterior ring ligamentous injuries.
Exclusion Criteria:
- Bony fracture of the pubic rami.
- Tile C2 and C3 pelvic ring injuries.
- Associated acetabular fracture that requires intervention.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group A will be fixed anteriorly first
Group A will consist of 15 patients and will be fixed anteriorly first.
|
The procedure will involve addressing the pelvic ring anteriorly with open reduction and internal fixation (ORIF) of the pubic rami and symphysis pubis by using a single 3.5 mm recon plate.
The goal isto achieve anatomical reduction and stable fixation to restore the integrity of the pelvic ring.
Fixation of the posterior ring will be achieved using a single sacroiliac screw in S1.
The goal of posterior fixation is to achieve stability and alignment of the posterior pelvic structures.
|
|
Active Comparator: Group B will be fixed posteriorly first
Group B: 15 cases, and will be fixed posteriorly first.
|
the procedure will involve fixation of the posterior ring which will be achieved by using a single sacroiliac screw in S1.
Then open reduction and internal fixation (ORIF) of the pubic rami and symphysis pubis by using a single 3.5 mm recon plate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiological outcome scores
Time Frame: 12 months
|
Patients will be followed up at two weeks, six weeks, three months, six months and one year postoperatively.
Matta & Tornetta radiological principles will be used to assess the radiological and clinical outcomes via plain X-ray of pelvis showing both hips through anteroposterior, inlet and outlet views.
Evaluation of five criteria on X-ray films postoperatively: residual posterior displacement, vertical displacement, pubic symphyseal translation, sagittal rotation and gapping of the sacroiliac joint.
According to the grading of Matta & Tornetta principles, results will be as follows; excellent (< 4 mm), good (4 - 10 mm), fair (10- 20 mm), and poor (> 20 mm).
|
12 months
|
|
Clinical outcome score
Time Frame: 12 months
|
Clinical outcome assessment at final follow up using Majeed pelvic score.
Five factors are assessed and scored: pain, standing, sitting, sexual intercourse and work performance.
The total score is then given a clinical grade as excellent, good, fair or poor.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time in minutes.
Time Frame: 3 hours
|
Operative time will be recorded in each group
|
3 hours
|
|
Implant failure rate
Time Frame: 12 months
|
Implant failure if any, will be recorded during follow up.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2024
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
November 23, 2024
First Submitted That Met QC Criteria
January 23, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 23, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU R230/2024
- No funds recieved (Other Identifier: Ainshams University)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Ring Injury
-
Duke UniversityWake Forest University Health Sciences; Orthopaedic Trauma Association; Prisma...Completed
-
Axel GamulinCompleted
-
Chonburi hospitalActive, not recruitingSacral Fractures | High-energy Trauma | Posterior Pelvic Ring InjuryThailand
-
Indiana UniversityTerminatedAnterior Pelvic Ring Injury With Symphysis DisruptionUnited States
-
Centre Hospitalier Universitaire de NiceCompletedPelvic Ring Tumor LesionsFrance
-
University of PennsylvaniaRecruitingGeriatric Pelvic Ring FracturesUnited States
-
Assiut UniversityNot yet recruitingSacral Fractures | Traumatic Unstable Sacral Fractures | Spinopelvic Dissociation | Pelvic Ring Injuries
-
University of Missouri-ColumbiaCompletedPelvic Ring FracturesUnited States
-
Indiana UniversityTerminatedAnterior Pelvic Ring FracturesUnited States
-
Zimmer BiometCompletedAcetabulum Fracture | Pelvic Ring FractureItaly
Clinical Trials on Starting by anterior ring fixation in vertical shear pelvic ring injuries
-
Ain Shams UniversityActive, not recruitingEvaluation of Single Symphyseal Plating in APC III InjuriesEgypt